Plasma Amyloid as Prescreener for the Earliest A lzheimer Pathological Changes-Reference-Cited by-同舟云学术

Plasma Amyloid as Prescreener for the Earliest A lzheimer Pathological Changes

Published:2018-10-04 Issue:5 Volume:84 Page:648-658
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Verberk Inge M. W.¹²³,Slot Rosalinde E.¹²,Verfaillie Sander C. J.¹²⁴,Heijst Hans¹³,Prins Niels D.¹²,van Berckel Bart N. M.¹⁴,Scheltens Philip¹²^ORCID,Teunissen Charlotte E.¹³,van der Flier Wiesje M.¹²⁵

Affiliation:

1. Amsterdam Neuroscience Amsterdam the Netherlands

2. Alzheimer Center Amsterdam, Department of NeurologyVU University Medical Center Amsterdam Amsterdam the Netherlands

3. Neurochemistry Laboratory, Department of Clinical ChemistryVU University Medical Center Amsterdam Amsterdam the Netherlands

4. Department of Radiology and Nuclear MedicineVU University Medical Center Amsterdam Amsterdam the Netherlands

5. Department of Epidemiology and BiostatisticsVU University Medical Center Amsterdam Amsterdam the Netherlands

Funder

Alzheimer Nederland

GE Healthcare

Center for Translational Molecular Medicine

Stichting Dioraphte

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.25334

Reference43 articles.

1. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

2. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

3. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

4. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

5. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An optimized UPLC-MS/MS method for human plasma amyloid-β 42 and 40 measurement and application in Alzheimer's disease diagnosis;Journal of Pharmaceutical and Biomedical Analysis;2024-11

2. Association between blood-based protein biomarkers and brain MRI in the Alzheimer’s disease continuum: a systematic review;Journal of Neurology;2024-09-12

3. Navigating the Landscape of Plasma Biomarkers in Alzheimer's Disease: Focus on Past, Present, and Future Clinical Applications;Neurology and Therapy;2024-09-07

4. A streamlined, resource-efficient immunoprecipitation-mass spectrometry method for quantifying plasma amyloid-β biomarkers in Alzheimer's disease;2024-09-02

5. Combined Serum Total Tau-Neurofilament Light Polypeptide Could be Used as Screening Biomarkers For Alzheimer’s Disease;2024-08-18